Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Sarepta Therapeutics Inc (NASDAQ:SRPT)

32.66
Delayed Data
As of Dec 09
 -1.83 / -5.31%
Today’s Change
8.00
Today|||52-Week Range
63.73
-15.34%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2015
Quarter 1
2016
Quarter 2
2016
Quarter 3
2016
Revenue and IncomeNet Revenues1.3M0.000.000.00
 
 
Depreciation And Amortization1.4M1.4M1.5M1.1M
 
 
 
 
 
 
Operating ExpensesGross Income---1.4M-1.5M-1.1M
 
 
 
 
General Expenses64.3M57.8M60.0M54.2M
 
 
 
 
 
Research And Development41.4M38.3M43.8M33.6M
 
 
 
 
 
Total Operating Expenses65.7M59.2M61.5M55.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-64.5M-59.2M-61.5M-55.3M
 
 
 
 
 
Extraordinary Charge---533.0K-626.0K-1.3M
 
 
 
 
Interest Expense On Debt229.0K68.0K201.0K209.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-64.7M-59.8M-62.3M-56.7M
 
 
 
 
 
Net Income-64.7M-59.8M-62.3M-56.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS44.9M45.7M46.2M48.3M
 
 
 
 
 
Shares To Calculate EPS Diluted44.9M45.7M46.2M48.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.44-$1.31-$1.35-$1.18
 
 
 
 
 
EPS Diluted-$1.44-$1.31-$1.35-$1.18